Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.
Liu YB, Chen MK.
World J Gastroenterol. 2022 Nov 7;28(41):5910-5930. doi: 10.3748/wjg.v28.i41.5910.
Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives.
Brown RS Jr, Brown KA, Flamm S, Bejarano RE, Rahimi RS, Singal AK, Rockey DC.
Hepatol Commun. 2025 Apr 3;9(4):e0682. doi: 10.1097/HC9.0000000000000682. eCollection 2025 Apr 1.
Portal hypertension.
Collini FJ, Brener B.
Surg Gynecol Obstet. 1990 Feb;170(2):177-92.
Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices.
Nakazawa M, Imai Y, Sugawara K, Uchida Y, Saitoh Y, Fujii Y, Uchiya H, Ando S, Nakayama N, Tomiya T, Mochida S.
PLoS One. 2022 Mar 15;17(3):e0264359. doi: 10.1371/journal.pone.0264359. eCollection 2022.
Comparison of gastrointestinal bleeding in patients with and without liver cirrhosis.
Daðadóttir SM, Ingason AB, Hreinsson JP, Björnsson ES.
Scand J Gastroenterol. 2024 Sep;59(9):1081-1086. doi: 10.1080/00365521.2024.2386451. Epub 2024 Aug 6.
Outcome of individuals with alcoholic cirrhosis hospitalized with first decompensation and their predictors.
Giri S, Ingawale S, Harindanath S, Jain M, Garg P, Darak H, Kumar S, Kale A, Shukla A.
Indian J Med Res. 2024 Feb 1;159(2):213-222. doi: 10.4103/ijmr.ijmr_1690_22. Epub 2024 Apr 4.
Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis.
Orloff MJ, Bell RH Jr, Hyde PV, Skivolocki WP.
Ann Surg. 1980 Sep;192(3):325-40. doi: 10.1097/00000658-198009000-00008.
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.
Poynard T, Calès P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D.
N Engl J Med. 1991 May 30;324(22):1532-8. doi: 10.1056/NEJM199105303242202.
Sclerotherapy of esophageal varices in hemophilia patients with liver cirrhosis - a prospective, controlled clinical study.
Szczepanik AB, Pielaciński K, Oses-Szczepanik AM, Huszcza S, Misiak A, Dąbrowski WP, Gajda S.
Pol Przegl Chir. 2018 Feb 28;90(1):29-34. doi: 10.5604/01.3001.0011.5957.
Bleeding risk in patients with esophageal varices undergoing transesophageal echocardiography.
Pantham G, Waghray N, Einstadter D, Finkelhor RS, Mullen KD.
Echocardiography. 2013 Nov;30(10):1152-5. doi: 10.1111/echo.12274. Epub 2013 Jun 6.
